The WTCCC study identified 49 SNPs putatively associated with rheumatoid arthritis at P ¼ 1 Â 10 À4 À 1 Â 10 À5 (tier 3). Here we show that three of these SNPs, mapping to chromosome 10p15 (rs4750316), 12q13 (rs1678542) and 22q13 (rs3218253), are also associated (trend P ¼ 4 Â 10 À5 , P ¼ 4 Â 10 À4 and P ¼ 4 Â 10 À4 , respectively) in a validation study of 4,106 individuals with rheumatoid arthritis and an expanded reference group of 11,238 subjects, confirming them as true susceptibility loci in individuals of European ancestry.
Rheumatoid arthritis is a common autoimmune disease, affecting an estimated 475,000 adults in the UK, in which inflammation of synovial joints is characteristic. The WTCCC genome-wide association screen of 1,860 rheumatoid arthritis cases and 2,938 healthy control individuals of European ancestry confirmed association of SNPs with previously identified loci within the HLA region and the PTPN22 gene (tier 1, P o 5 Â 10 À7 ) 1 . Nine loci were associated in the next tier of significance (tier 2, P ¼ 1 Â 10 À5 -5 Â 10 À7 ), and association to one loci on chromosome 6q23 has been replicated and confirmed in subsequent independent studies 2, 3 . Forty-nine SNPs were associated at P ¼ 1 Â 10 À4 -1 Â 10 À5 (tier 3), and we now describe investigation of these SNPs in an independent cohort of 4,106 individuals with rheumatoid arthritis (Supplementary Methods and Supplementary Table 1 online). The study was undertaken with ethical approval, and all subjects provided informed consent. Causal variants within this group of SNPs are likely to confer small effect sizes, by virtue of the fact that the evidence for association with them in the original WTCCC study was weaker than for those SNPs in tiers 1 and 2. In order to maximize power to replicate true associations, we combined genotype data from an independent cohort of 3,599 healthy controls with that from the group of subjects with four non-autoimmune diseases (coronary artery disease, hypertension, type 2 diabetes and bipolar disorder) genotyped as part of the WTCCC study to create a large reference sample (total sample size of expanded reference group ¼ 11,238) 1 . A Bonferroni correction of 49 was applied to account for the loci investigated, resulting in a Pvalue threshold of P o 0.001 for claims of significance in this validation study. The validation cohort had 80% power to detect most of the effect sizes reported in the initial study at P o 0.001 (Supplementary Table 2 online). In addition, we took the opportunity to reevaluate the evidence for association with the tier 2 SNPs using the expanded reference group for comparison.
Of the 49 tier 3 SNPs tested, three showed association with rheumatoid arthritis: rs4750316 (C4G), mapping to chromosome 10p15 (OR minor allele ¼ 0.87, 95% CI ¼ 0.81-0.93, trend P ¼ 4 Â 10 À5 ); rs1678542 (G4C), mapping to chromosome 12q13 (OR minor allele ¼ 0.91, 95% CI ¼ 0.86-0.96, trend P ¼ 4 Â 10 À4 ); and rs3218253 (C4T), mapping to chromosome 22 (OR minor allele ¼ 1.11, 95% CI ¼ 1.05-1.17, trend P ¼ 4 Â 10 À4 ) ( Rheumatoid arthritis is characterized by the presence of autoantibodies in some but not all affected individuals. Previous work has shown that established susceptibility variants, including HLA-DRB1 and the chromosome 6q23 locus, have a stronger effect in the subgroup harboring antibodies to citrullinated peptide antibodies (ACPA) recognized by the anti-CCP assay 2, 4 . Stratification analysis showed that, for all 3 loci, the direction and strength of effect size was similar in individuals both positive and negative for the antibodies, although this did not always achieve statistical significance in the anti-CCP-negative subgroup owing to the smaller sample size (Supplementary Table 5 online). Hence, these loci seem to be associated with rheumatoid arthritis per se rather than a particular subgroup of the disease. rs4750316 maps to an intergenic region of 10p15. Four SNPs genotyped by the HapMap Consortium (rs10752291, rs10796045, rs2146900 and rs1570527) in the same region have a pairwise r 2 4 0.96 with rs4750316 and all five SNPs map within 12 kb of each other in a single linkage disequilibrium (LD) block containing no known genes or transcripts ( Supplementary Fig. 1 online) . The closest gene, PRKCQ, lies 76 kb from rs4750316 and encodes an atypical member of the protein kinase C family of proteins, PKCy. It is thought to have a key role in T-cell activation, and PKCy-deficient T cells in mice show a profound defect in IL-2 production and proliferation upon stimulation by antibodies to CD3 or CD28 (reviewed in ref. 5). As rheumatoid arthritis is thought to be primarily a T-cell-mediated autoimmune disease, investigating the role of the associated SNPs in regulation of the PRKCQ gene will be a priority.
rs1678542 maps to intron 15 of the KIF5A gene ( Supplementary  Fig. 1 ). KIF5A encodes a kinesin heavy chain, and mutations of KIF5A have been associated with hereditary spastic paraplegia 6 . Hence, it is not an obvious candidate susceptibility gene for rheumatoid arthritis. KIF5A maps between the DCTN2 (dynactin 2) and the PIP4K2C (phosphatidylinositol-5-phosphate 4-kinase, type II, gamma) genes. The latter is expressed in B cells and is thought to have a role in B-cell receptor activation as well as in development and function of B cells 7 ; therefore, it is a stronger candidate for a disease characterized by the presence of autoantibodies. There are now several examples where an associated variant mapping within one gene has subsequently been found to regulate a different gene, but further investigation is required to determine whether this is true of the rs1678542 polymorphism 8, 9 .
rs3218253 maps to the IL2RB (interleukin 2 receptor, beta) gene ( Supplementary Fig. 1 ). We have previously reported borderline evidence for association with another SNP in the gene (rs743777) 2 . Combining the data from the validation cases, the expanded reference group and original WTCCC data, we found that the evidence for association of the rs743777 SNP was strengthened (trend P ¼ 4.6 Â 10 À8 ; Table 2 ). For both SNPs, the evidence for association was even stronger under a recessive model (rs3218253 P ¼ 4.4 Â 10 À8 and rs743777 P ¼ 5.2 Â 10 À9 , respectively). rs743777 maps 6 kb upstream of the transcription start site of IL2RB, whereas rs3218253 maps to intron 1, but both SNPs lie within a single LD block spanning 6.8 kb and show reasonable correlation with each other (r 2 ¼ 0.77). Therefore, we carried out haplotype analysis. Haplotype frequencies were significantly different between cases and controls (rs743777
, but the effect of the haplotype of minor alleles at each locus was not significantly increased over that of the minor allele at rs743777 alone (data not shown). Furthermore, logistic regression analysis suggested that the effect at rs3218253 could be fully accounted for by the genotype at rs743777, suggesting that the latter SNP is primarily driving the association and the association with rs3218253 is arising as a result of its LD with rs743777 (P value for rs3218253 after conditioning on rs743777 ¼ 0.60). The IL2RB gene is an attractive candidate for an autoimmune disease because of the key role played by IL2 in T-cell activation and regulation. The IL2RB gene encodes the beta unit of the IL2R, which is present in the moderate-and high-affinity forms of the receptor required for signal transduction from IL2 (ref. 10) .
Given that the evidence for association with IL2RB was strengthened by analyzing all the available data, including the expanded reference cohort, we were interested to investigate whether evidence for association with any of the other SNPs tested previously from tier 2 would also be increased. In the expanded validation samples, five of the nine tier 2 SNPs showed evidence for association (P o 0.05) and, in a combined analysis of 6,923 rheumatoid arthritis cases and 14,425 combined reference samples, the strength of evidence for association for four of these five loci was increased over that seen in the original WTCCC study ( Table 2) . These included the SNP mapping to 6q23, which has previously been confirmed independently as being associated with rheumatoid arthritis susceptibility, and the IL2RB SNP (rs743777) already discussed 2, 3 . In addition, the evidence for association with SNPs mapping to the MMEL1 (membrane metallo-endopeptidase-like 1) and IL2RA genes (OR ¼ 0.90, 95% CI ¼ 0.86-0.94, P ¼ 8.2 Â 10 À6 and OR ¼ 0.90 95% CI ¼ 0.86-0.94, P ¼ 6.4 Â 10 À6 , respectively) was enhanced. Notably, evidence for association of a SNP mapping to the MMEL1 gene region has also been reported (P ¼ 0.01) in analysis of an independent cohort of rheumatoid arthritis cases and controls from Europe and the United States. Furthermore, that study also independently replicates the findings for the PRKCQ and KIF5A loci reported here (P ¼ 0.03 and 0.009, respectively), suggesting that these regions harbor true rheumatoid arthritis susceptibility variants with modest but important effects 11 .
In conclusion, we have newly identified rheumatoid arthritis susceptibility loci mapping close to the PRKCQ and KIF5A genes in individuals of European ancestry, and evidence for a recessive effect at a third, the IL2RB gene, is compelling. In addition, evidence for association with the MMEL1 and IL2RA gene regions is mounting. 
